Progress of stent fracture in the femoral and popliteal arteries

doi:10.3877/cma.j.issn.1674-0793.2015.01.015

Abstract

Abstract:

Endovascular treatment has been the first-line therapeutic strategy for arteriosclerosis obliterans. With the advancement of endovascular procedure and improvement of stent material, stent repair of severe stenosis and occlusion in femoral and popliteal arteries is satisfying. However, studies have demonstrated that stent fracture can induce the tough issue of in-stent restenosis, which would influence the primary patency. The current research progress and strategy of stent fracture in the femoral and popliteal arteries are reviewed.

Key words: Femoral and popliteal arteries, Stent, Fracture

Baolei Guo, Daqiao Guo, Weiguo Fu. Progress of stent fracture in the femoral and popliteal arteries[J]. Chinese Archives of General Surgery(Electronic Edition), 2015, 09(01): 58-61.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2015.01.015

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2015/V09/I01/58

References 25

[1]	Duda SH,Pusich B,Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: sixmonth results[J]. Circulation, 2002, 106(12): 1505-1509.
[2]	Rits J,van Herwaarden JA,Jahrome AK, et al. The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings[J]. Eur J Vasc Endovasc Surg, 2008, 36(3): 339-345.
[3]	Laird JR,Katzen BT,Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial[J]. J Endovasc Ther, 2012, 19(1): 1-9.
[4]	Suzuki K,Iida O,Soga Y, et al. Long-term results of the S.M.A.R.T. Control (TM) stent for superficial femoral artery lesions, J- SMART registry[J]. Circ J, 2011, 75(4): 939-944.
[5]	Schillinger M,Sabeti S,Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery[J]. New Engl J Med, 2006, 354(18): 1879-1888.
[6]	Davaine JM,Quérat J,Guyomarch B, et al. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year[J]. Eur J Vasc Endovasc Surg, 2013,46(2):201-212.
[7]	Krankenberg H,Schlueter M,Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)[J]. Circulation, 2007, 116(3): 285-292.
[8]	Karnabatidis D,Katsanos K,Spiliiopoulos S, et al. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents[J]. J Endovasc Ther, 2009, 16(1): 15-22.
[9]	Allie D,Herbert C,Walker C. Nitinol stent fractures in the SFA[J]. Endovasc Today, 2004, 3: 22-34.
[10]	Jaff M,Dake M,Pornpa J, et al. Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices[J]. Catheter Cardio Inte,2007, 70(3): 460-462.
[11]	Doi H,Maehara A,Mintz GS, et al. Intravascular ultrasound findings of stent fractures in patients with Sirolimus-and Paclitaxeleluting stents[J]. Am J Cardiol, 2010, 106(7): 952-957.
[12]	Adlakha S,Sheikh M,Wu J, et al. Stent fracture in the coronary and peripheral arteries[J]. J Interv Cardiol, 2010, 23(4): 411-419.
[13]	Watanabe T,Tamura A,Miyamoto K, et al. Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture[J]. Int J Cardiol, 2010, 140(1): e12-13.
[14]	Nikanorov A,Smouse HB,Osman K, et al. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions[J]. J Vasc Surg, 2008, 48(2): 435-440.
[15]	Laird JR,Katzen BT,Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery twelve-month results from the RESILIENT randomized trial[J]. CircCardiovasc Interv, 2010, 3(3): 267-276.
[16]	Schlager O,Dick P,Sabeti S, et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures[J]. J Endovasc Ther, 2005, 12(6): 676-684.
[17]	Bates MC,Campbell JR,Campbell JE. Late complication of stent fragmentation related to the "lever-arm effect"[J]. J Endovasc Ther, 2008, 15(2): 224-230.
[18]	Cheng CP,Wilson NM,Hallett RL, et al. In vivo MR angiographic quantification of axial and twisting deformations of the superficial femoral artery resulting from maximum hip and knee flexion[J]. J Vasc Interv Radiol, 2006, 17(6): 979-987.
[19]	Scheinert D,Scheinert S,Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting[J]. J Am Coll Cardiol, 2005, 45(2): 312-315.
[20]	Otsuka F,Nakano M,Sakakura K, et al. Unique demands of the femoral anatomy and pathology and the need for unique interventions[J]. J Cardiovasc Surg, 2013, 54(2): 191-210.
[21]	Iida O,Nanto S,Uematsu M, et al. Effect of exercise on frequency of stent fracture in the superficial femoral artery[J]. Am J Cardiol, 2006, 98(2): 272-274.
[22]	Adlakha S,Sheikh M,Wu J, et al. Stent fracture in the coronary and peripheral arteries[J]. J Interv Cardiol, 2010, 23(4): 411-419.
[23]	Tosaka A,Soga Y,Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting[J]. J Am Coll Cardiol, 2012, 59(1): 16-23.
[24]	Bosiers M,Deloose K,Keirs EK, et al. Prevention and treatment of in-stent restenosis[J]. J Cardiovasc Surg, 2010, 51(4): 591-598.
[25]	Higashiura W,Sakaguchi S,Morimoto K, et al. Stent fracture and reocclusion after placement of a single self-expanding stent in the common iliac artery and endovascular treatment[J]. Cardiovasc Inter Radiol, 2008, 31(5): 1013-1017.

Please choose a citation manager

Content to export